MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 49 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,891,381 | -5.2% | 511,351 | +1.8% | 0.05% | -8.8% |
| Q3 2022 | $4,105,000 | +12.9% | 502,411 | +33.6% | 0.06% | +1.8% |
| Q2 2022 | $3,636,000 | +439.5% | 376,008 | +681.7% | 0.06% | +409.1% |
| Q1 2022 | $674,000 | -31.3% | 48,100 | +0.2% | 0.01% | -21.4% |
| Q4 2021 | $981,000 | -67.1% | 48,025 | -64.2% | 0.01% | -71.4% |
| Q3 2021 | $2,986,000 | -36.8% | 134,033 | -35.6% | 0.05% | -44.3% |
| Q2 2021 | $4,723,000 | – | 208,068 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $11,469,458 | 5.52% |
| NEA Management Company, LLC | 7,692,298 | $59,923,001 | 4.14% |
| Cormorant Asset Management, LP | 2,893,717 | $22,542 | 1.48% |
| Alphabet Inc. | 1,464,015 | $11,404,677 | 0.63% |
| Avoro Capital Advisors LLC | 4,325,000 | $33,691,750 | 0.50% |
| Casdin Capital, LLC | 510,882 | $3,979,771 | 0.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $242,705 | 0.10% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $219,616 | 0.04% |
| UBS OCONNOR LLC | 95,528 | $744,163 | 0.02% |
| ExodusPoint Capital Management, LP | 261,593 | $2,038 | 0.02% |